Kane Biotech
Kane Biotech is a Canadian-based biotechnology company focused on the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms. Their mission is to license their anti-biofilm technologies to global industry players, initially in the pet animal health market and then in human health. They have developed proprietary products and hold a portfolio of patents and patents pending, primarily targeting biofilm-related problems across healthcare, food processing, domestic applications, and more.
Industries
Nr. of Employees
small (1-50)
Kane Biotech
290-100 Innovation Drive, Winnipeg, Manitoba, Canada, R3T 6G2
Patents
Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products
US-11723852-B2
View DetailsAntimicrobial-antibiofilm compositions and methods of use thereof for personal care products
US-11103433-B2
View Details
Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products
US-11723852-B2
View DetailsAntimicrobial-antibiofilm compositions and methods of use thereof for personal care products
US-11103433-B2
View DetailsProducts
Antimicrobial wound gel (thermo-reversible hydrogel)
Topical thermo-reversible hydrogel designed to destabilize biofilm and provide a moist wound environment; formulated for ease of application, retention on wound surface, and rinsability.
Antimicrobial wound gel spray (spray-to-gel)
Liquid spray formulation that forms a gel on contact with body temperature for topical wound and burn applications, incorporating antibiofilm actives.
Antibiofilm enzyme formulations (development pipeline)
Enzyme-based formulations intended for wound, otic and dermatological applications that cleave biofilm polysaccharides to enable bacterial eradication; pipeline includes combinations with antibiotics.
Scalp and dermatology consumer products (development and testing)
Topical scalp and skin formulations intended to reduce symptoms associated with dandruff, seborrheic dermatitis and other inflammatory skin conditions by attacking biofilms on the skin surface.
Antimicrobial wound gel (thermo-reversible hydrogel)
Topical thermo-reversible hydrogel designed to destabilize biofilm and provide a moist wound environment; formulated for ease of application, retention on wound surface, and rinsability.
Antimicrobial wound gel spray (spray-to-gel)
Liquid spray formulation that forms a gel on contact with body temperature for topical wound and burn applications, incorporating antibiofilm actives.
Antibiofilm enzyme formulations (development pipeline)
Enzyme-based formulations intended for wound, otic and dermatological applications that cleave biofilm polysaccharides to enable bacterial eradication; pipeline includes combinations with antibiotics.
Scalp and dermatology consumer products (development and testing)
Topical scalp and skin formulations intended to reduce symptoms associated with dandruff, seborrheic dermatitis and other inflammatory skin conditions by attacking biofilms on the skin surface.
Services
Quantitative and qualitative assays for biofilm and planktonic antimicrobial activity, including MBEC-type testing and work with aerobic/anaerobic organisms and spores.
Development of topical and spray-to-gel formulations, enzyme–antibiotic combination prototypes, and thermo-reversible hydrogel systems.
On-site GMP-certified manufacturing for production of topical formulations intended for clinical, veterinary or consumer markets.
Design and conduct of consumer and clinical studies for topical products including informed consent, product shipping, questionnaires and photo documentation.
QC release testing and stability studies to support product claims and regulatory filings.
Quantitative and qualitative assays for biofilm and planktonic antimicrobial activity, including MBEC-type testing and work with aerobic/anaerobic organisms and spores.
Development of topical and spray-to-gel formulations, enzyme–antibiotic combination prototypes, and thermo-reversible hydrogel systems.
On-site GMP-certified manufacturing for production of topical formulations intended for clinical, veterinary or consumer markets.
Design and conduct of consumer and clinical studies for topical products including informed consent, product shipping, questionnaires and photo documentation.
QC release testing and stability studies to support product claims and regulatory filings.
Expertise Areas
- Biofilm research and disruption
- Topical wound-care formulation development
- Enzyme-based antibiofilm therapeutics
- Microbiology and biofilm analytical testing
Key Technologies
- Enzymatic PNAG degradation
- Metal ion chelation (EDTA-based) formulations
- pH-buffering formulations (citrate/citric acid)
- Thermo-reversible hydrogel systems
News & Updates
Conference where Kane Biotech presented recent data on their wound care products.
Conference where Kane Biotech presented posters on wound care.
Webinar featuring Kane Biotech CEO Marc Edwards.
Conference where Kane Biotech presented recent data.
Conference where Kane Biotech presented a poster on wound care.
Award received by Kane Biotech from Bioscience Association Manitoba.
Conference where Kane Biotech presented recent data on their wound care products.
Conference where Kane Biotech presented posters on wound care.
Webinar featuring Kane Biotech CEO Marc Edwards.
Conference where Kane Biotech presented recent data.
Conference where Kane Biotech presented a poster on wound care.
Award received by Kane Biotech from Bioscience Association Manitoba.